0OIR.LSE News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

Loading chart

Pay with

0O

Mkt Cap

N/A

Volume

167.27K

Next Earnings

N/A

Chart Earnings News About Insider Filings

Grant of share-based long-term incentive instruments to members of the Board of Management and key employeesALK Abello ALK (ALKB:DC / OMX: ALK B / AKBLF): According to the company’s remuneration policy adopted at the company's Annual General Meeting on 14 March 2024 and in line with the company’s usual practice, the Board of Directors has passed a resolution to grant up to a total of 2…finance.yahoo.com · Apr 3, 2025

Annual General Meeting in ALK-Abelló A/S held on 13 March 2025ALK Abello ALK (ALKB:DC / OMX: ALK B / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 13 March 2025. The Annual General Meeting transacted the following business: Approval of the annual report 2024 and discharge of the Board of Directors and Board of Management Resolut…finance.yahoo.com · Mar 13, 2025

ACARIZAX® approved in Canada for treatment of young childrenALK Abello ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children, aged five to 11, with house dust mite (HDM) allergy. ACARIZAX® is now indicated for treatment of moderate to severe HDM-induced allergic rhinitis, wit…finance.yahoo.com · Mar 7, 2025

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staffALK Abello ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions by managerial staff: The Board of Directors h…finance.yahoo.com · Mar 4, 2025

U.S. FDA Approves Label Expansion for ALK's ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy- ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years of age – - House dust mites are a common cause of allergies in children and can ca…finance.yahoo.com · Feb 28, 2025

FDA approves ODACTRA® for the treatment of house dust mite allergy in young childrenALK Abello ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK’s ODACTRA® tablet for use in young children with house dust mite (HDM) allergy. ODACTRA® is now indicated to treat HDM-induced allergic rhinitis, with or without …finance.yahoo.com · Feb 27, 2025

Annual General Meeting in ALK-Abelló A/S on 13 March 2025ALK Abello ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 13 March 2025 at 4:00 PM (CET) at ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm, Denmark. The agenda of the meeting including the complete proposals from the Boar…finance.yahoo.com · Feb 19, 2025

Annual report 2024: ALK delivers 15% sales growth with profits up 65%ALK Abello ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the 2024 annual report. Following a robust performance in Q4, full-year results were in line with the latest outlook and represent the best results in the history of the company. ALK expects to contin…finance.yahoo.com · Feb 19, 2025

Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025ALK Abello ALK (ALKB:DC / OMX: ALK B / AKBLF) will publish its annual report for 2024 in the morning on Wednesday, 19 February 2025. Later on the same day, the company will host a presentation for investors and analysts at 1:30 p.m. CET, where ALK’s management will comment on the…finance.yahoo.com · Feb 12, 2025

ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health systemALK Abello ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to severe house dust mite allergic rhinitis in adults and adolescents. Th…finance.yahoo.com · Jan 30, 2025

to start trading

0O

0OIR.LSE0OIR.LSE

0OIR.LSE

Pay with—

Available Balance0.00

Your PositionYou don't own any 0OIR.LSE yet.

Related Tickers

Earnings